Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients.

about

The Prevalence and Clinical Relevance of ASA Nonresponse After Cardiac Surgery: A Prospective Bicentric Study.Effects of magnesium sulphate on coagulation after laparoscopic colorectal cancer surgery, measured by rotational thromboelastometry (ROTEM® ).

P2860

Q47318700-972D237C-4DD1-485F-9152-3C7CAAEC9A10 Q47828398-01B86545-82B9-4A60-91A3-536983CCA621

P2860

Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients.

Item

http://www.wikidata.org/entity/Q36030498

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Assessment of the risk and the ...... embolism in surgical patients.

@ast

Assessment of the risk and the ...... embolism in surgical patients.

@en

type

Item

label

Assessment of the risk and the ...... embolism in surgical patients.

@ast

Assessment of the risk and the ...... embolism in surgical patients.

@en

prefLabel

Assessment of the risk and the ...... embolism in surgical patients.

@ast

Assessment of the risk and the ...... embolism in surgical patients.

@en

P1476

Assessment of the risk and the ...... embolism in surgical patients.

@en

P2093

David Bergqvist

http://www.w3.org/2001/XMLSchema#string

P2860

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humans.

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.

P304

358-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000083829

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15692244

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients.

about

P2860

P2860

Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921